FDA Cites ARJ Infusion Services Over GMPs

Drug GMP Report
A A
The FDA found substantial sterility problems on a visit to Kansas-based ARJ Infusion Services, makers of in-home intravenous medications for adults and children with rare and chronic conditions.

To View This Article:

Login

Subscribe To Drug GMP Report